Josh

About Josh Rodriguez

Joshua Rodriguez is the owner and founder of CNA Finance. He is also a partner here at Modest Money. His analysis has been featured on Investing.com, Yahoo! Finance, Google Finance, Google News, and many others. To connect with Joshua, follow him on Twitter @CNAFinance.
Cellectar Biosciences (CLRB) Stock: Gaining Big on Patent News
  • Cellectar Biosciences (CLRB) Stock: Gaining Big on Patent News

Cellectar Biosciences (CLRB) Stock: Gaining Big on Patent News

By |January 24th, 2017|

Cellectar Biosciences Inc (NASDAQ: CLRB)

Cellectar Biosciences is having an incredibly strong day in the market today, and for good reason. In pre-market hours, it was announced that the company has been awarded a new patent, sending the stock spiking upward dramatically. Below, we’ll talk about the patent, what we saw in the market as […]

BioLineRx (BLRX) Stock: An Interesting Opportunity in the Making?
  • BioLineRx (BLRX) Stock: An Interesting Opportunity in the Making?

BioLineRx (BLRX) Stock: An Interesting Opportunity in the Making?

By |January 23rd, 2017|

BioLineRx Ltd (NASDAQ: BLRX)

One of the things I love about my job is the fact that I tend to find opportunities in the market early on. This one, BioLineRx was brought to my attention by a friend at an IR firm. After a quick conversation, I decided that it was time to start doing […]

TransDigm Group (TDG) Stock: Falling Apart as Trump Takes Office
  • TransDigm Group (TDG) Stock: Falling Apart as Trump Takes Office

TransDigm Group (TDG) Stock: Falling Apart as Trump Takes Office

By |January 20th, 2017|

TransDigm Group Incorporated (NYSE: TDG)

TransDigm Group is having an incredibly hard time in the market today. When the trading session opened for the day, the stock was already trading slightly in the red, but no one expected what we would see just 15 minutes in. A report was published by Citron Research that sent […]

Trading With The News: A Surefire Strategy
  • Trading With The News: A Surefire Strategy

Trading With The News: A Surefire Strategy

By |January 20th, 2017|

If you’re a trader, whether a beginner or a professional, you know the importance of strategy. At the end of the day, your trading strategy is the what, when, and why, of just about every trade you will make in the market. Throughout the years, I’ve tried various strategies; some successfully, some not so […]

Regulation A+ Is Changing The Game In The Investment Space
  • Regulation A+ Is Changing The Game In The Investment Space

Regulation A+ Is Changing The Game In The Investment Space

By |January 19th, 2017|

If you’re an investor, you may or may not have heard about new SEC regulation known as Regulation A+. However, it is likely a regulation that will drastically change the game for those looking to get involved in smaller companies that offer tremendous growth opportunities. Today, we’ll talk about what Regulation A+ is, a […]

Get Ready for a Wild Ride in the Market
  • Get Ready for a Wild Ride in the Market

Get Ready for a Wild Ride in the Market

By |January 17th, 2017|

The stock market has been incredibly interesting to follow as of late, and for good reason. At the end of the day, there’s a lot going on with regard to the global economy, and it’s all centered in three regions, the United States, the UK, and the European Union. Today, we’ll talk about what’s […]

Asterias Biotherapeutics (AST) Stock: Should You Buy the Dip?
  • Asterias Biotherapeutics (AST) Stock: Should You Buy the Dip?

Asterias Biotherapeutics (AST) Stock: Should You Buy the Dip?

By |January 11th, 2017|

Asterias Biotherapeutics Inc (NYSEMKT: AST)

Asterias Biotherapuetics has had a relatively strong run over the past several trading sessions. However, today, the same can’t be said. Unfortunately, the stock is down today. However, is this something to be concerned about or is it more of an opportunity. Today, we’ll talk about what we’re seeing from […]

Valeant Pharmaceuticals (VRX) Stock: Here's Why It's Up!
  • Valeant Pharmaceuticals (VRX) Stock: Here's Why It's Up!

Valeant Pharmaceuticals (VRX) Stock: Here’s Why It’s Up!

By |January 10th, 2017|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals had an incredibly strong start to the trading session this morning. When the opening bell rang, the stock was trading well into the green. While the stock has been experiencing slow, yet steady gains throughout the day, it is still trading with very strong profits at the […]

Here's Why Oil Is Falling Today
  • Here's Why Oil Is Falling Today

Here’s Why Oil Is Falling Today

By |January 9th, 2017|

Oil has been on a strong run upward recently, and for good reason. The world is paying close attention to supply cuts from OPEC and non-OPEC member nations. However, many experts have pointed out that the oil supply cuts would not be an end-all, be-all for oil. In fact, they have been warning that […]

Fibrocell Science (FCSC) Stock: Buy the Dip!
  • Fibrocell Science (FCSC) Stock: Buy the Dip!

Fibrocell Science (FCSC) Stock: Buy the Dip!

By |January 6th, 2017|

Fibrocell Science Inc (NASDAQ: FCSC)

Fibrocell Science had an incredible day in the market yesterday. However, today, the stock is taking a bit of a dip. Since the opening bell, the stock has been teetering near the break-even point, spending most of the day in the red. While this may be concerning to some, to […]